Navigation Links
Cancer Drug Banned in England

Cancer drug Velcade has been banned in England because the Government’s drugs rationing watchdog, National Institute for Health and Clinical Excellence (NICE) has refused// to fund treatment, according to last night’s claims.

NICE has planned to announce next week that Velcade should not be offered on the NHS to treat multiple myeloma, a cancer of the bone marrow. Presently a course of Velcade has been estimated to cost between £9,000 and £18,000 and was already approved for use in Scotland in 1994.

Cancer sufferers and cancer charities criticized the decision by NICE, saying this was their latest attempt saving the Government money by rejecting drugs that increase life expectancy. Since June, NICE has refused to endorse five treatments including treatment for bowel cancer, leukaemia and breast cancer, as well as Alzheimer’s disease that would grant an extension to peoples’ lives suffering from these diseases.

As one cancer sufferer said: “Are they saying a Scottish life is worth more than an English life? “They are effectively saying to people with incurable diseases, ‘sit down in a darkened room and die’.”

NICE has refused to comment on next week’s announcement. A NICE spokesman said: “NICE’s expert advisers review all the evidence on cancer treatments to determine whether they add benefits for patients when compared to other treatments that are already available.

“The benefits that we assess include whether a drug extends life, and whether a drug improves patients’ quality of life.”

A Department of Health spokesman has refused to comment until the guidance was published.

SourceMedindia
NLA
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: